Conversation with Tyler Norris
The second Delphi Insight Session features a conversation with Tyler Norris on the integration of psychedelics into the broader healthcare system, the challenges, and roadmap towards making this integration happen.
Economic Impacts, Therapeutic Advances, and Emotional Benefits
New psychedelic studies highlight ketamine’s economic benefits, psilocybin’s spiritual impact, and DMT’s potential therapeutic uses.
Scaling Psychedelics
In this session, you’ll learn about the essential organizations and activities we must focus on now to ensure psychedelics can be brought to scale as soon as possible after FDA approval.
Delphi’s Strategic Outlook
The first Delphi Insight Session – an introduction to Delphi, our work, and our vision for an integrated future.
Rapid and Sustained Psychedelic Treatments Show Promise in Recent Clinical Trials
Recent psychedelic research provides crucial insights for drug developers, advocates, and policy leaders, demonstrating the practical potential of psychedelic treatments to transform mental health care delivery.
